Septemeber 2020 updates to the website

The website has now been updated following September's LSCMMG

The following guidelines have been added/updated:

Home monitoring of blood glucose - Guideline - update
Management of Psoriasis in Primary Care - Guideline - update

The following Items will be ratified and added to the website following Joint Committee of CCGs (JCCCG) Meeting:

Dibotermin alfa (InductOs®) - for the treatment of acute tibia Gustilo-Anderson grade IIIB fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation (licensed indication)

Dibotermin alfa (InductOs®) - for use outside of the licensed indication for the treatment of non-union long bone fractures

Rifaximin - Second line antibacterial treatment for the treatment of Small Intestinal Bacterial Overgrowth

Linezolid - Pneumonia, skin and soft-tissue infections

Vaco Cast Diabetic - Pneumonia, skin and soft-tissue infections

Psoriasis: LSCMMG Biologic and High Cost Drug Commissioning Pathway - Update

Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy - Update

Pneumococcal and Haemophilus type b / Meningococcal (Menitorix) group C Vaccines - Use in adults with low antibody levels

Melatonin - Melatonin Prolonged Release Tablets (Circadin®) for the Treatment of Rapid Eye Movement (REM) Sleep Behaviour Disorder (RBD) in Parkinson’s Disease

Linezolid - Pneumonia, skin and soft-tissue infections

Pregabalin - Treatment of GAD